Recent studies have established cell type– specific, proapoptotic, or antiapoptotic functions for the transcription factor NF-κB. In each of these studies, inhibitors of NF-κB activity have been present before the apoptotic stimulus, and so the role of stimulus- induced NF-κB activation in enhancing or inhibiting survival could not be directly assessed. Sindbis virus, an alphavirus, induces NF-κB activation and apoptosis in cultured cell lines. To address whether Sindbis virus– induced NF-κB activation is required for apoptosis, we used a chimeric Sindbis virus that expresses a superrepressor of NF-κB activity. Complete suppression of virus-induced NF-κB activity neither prevents nor potentiates Sindbis virus–induced apoptosis. In contrast, inhibition of NF-κB activity before infection inhibits Sindbis virus–induced apoptosis. Our results demonstrate that suppression of steady-state, but not stimulus-induced NF-κB activity, regulates expression of gene products required for Sindbis virus–induced death. Furthermore, we show that in the same cell line, NF-κB can be proapoptotic or antiapoptotic depending on the death stimulus. We propose that the role of NF-κB in regulating apoptosis is determined by the death stimulus and by the timing of modulating NF-κB activity relative to the death stimulus.
Skip Nav Destination
Article navigation
29 June 1998
Article|
June 29 1998
Suppression of Steady-state, but not Stimulus-induced NF-κB Activity Inhibits Alphavirus-induced Apoptosis
Kuo-I Lin,
Kuo-I Lin
*Department of Molecular Microbiology and Immunology, The Johns Hopkins University School of Public Health, Baltimore, Maryland 21205; ‡Department of Medicine, University of California, San Diego, La Jolla, California 92093; §Department of Biology, Massachusetts Institute of Technology, Boston, Massachusetts 02114; and ‖Department of Neurology and Program in Neuroscience, Harvard Medical School and Beth Israel-Deaconess Medical Center, Boston, Massachusetts 02115
Search for other works by this author on:
Joseph A. DiDonato,
Joseph A. DiDonato
*Department of Molecular Microbiology and Immunology, The Johns Hopkins University School of Public Health, Baltimore, Maryland 21205; ‡Department of Medicine, University of California, San Diego, La Jolla, California 92093; §Department of Biology, Massachusetts Institute of Technology, Boston, Massachusetts 02114; and ‖Department of Neurology and Program in Neuroscience, Harvard Medical School and Beth Israel-Deaconess Medical Center, Boston, Massachusetts 02115
Search for other works by this author on:
Alexander Hoffmann,
Alexander Hoffmann
*Department of Molecular Microbiology and Immunology, The Johns Hopkins University School of Public Health, Baltimore, Maryland 21205; ‡Department of Medicine, University of California, San Diego, La Jolla, California 92093; §Department of Biology, Massachusetts Institute of Technology, Boston, Massachusetts 02114; and ‖Department of Neurology and Program in Neuroscience, Harvard Medical School and Beth Israel-Deaconess Medical Center, Boston, Massachusetts 02115
Search for other works by this author on:
J. Marie Hardwick,
J. Marie Hardwick
*Department of Molecular Microbiology and Immunology, The Johns Hopkins University School of Public Health, Baltimore, Maryland 21205; ‡Department of Medicine, University of California, San Diego, La Jolla, California 92093; §Department of Biology, Massachusetts Institute of Technology, Boston, Massachusetts 02114; and ‖Department of Neurology and Program in Neuroscience, Harvard Medical School and Beth Israel-Deaconess Medical Center, Boston, Massachusetts 02115
Search for other works by this author on:
Rajiv R. Ratan
Rajiv R. Ratan
*Department of Molecular Microbiology and Immunology, The Johns Hopkins University School of Public Health, Baltimore, Maryland 21205; ‡Department of Medicine, University of California, San Diego, La Jolla, California 92093; §Department of Biology, Massachusetts Institute of Technology, Boston, Massachusetts 02114; and ‖Department of Neurology and Program in Neuroscience, Harvard Medical School and Beth Israel-Deaconess Medical Center, Boston, Massachusetts 02115
Search for other works by this author on:
Kuo-I Lin
*Department of Molecular Microbiology and Immunology, The Johns Hopkins University School of Public Health, Baltimore, Maryland 21205; ‡Department of Medicine, University of California, San Diego, La Jolla, California 92093; §Department of Biology, Massachusetts Institute of Technology, Boston, Massachusetts 02114; and ‖Department of Neurology and Program in Neuroscience, Harvard Medical School and Beth Israel-Deaconess Medical Center, Boston, Massachusetts 02115
Joseph A. DiDonato
*Department of Molecular Microbiology and Immunology, The Johns Hopkins University School of Public Health, Baltimore, Maryland 21205; ‡Department of Medicine, University of California, San Diego, La Jolla, California 92093; §Department of Biology, Massachusetts Institute of Technology, Boston, Massachusetts 02114; and ‖Department of Neurology and Program in Neuroscience, Harvard Medical School and Beth Israel-Deaconess Medical Center, Boston, Massachusetts 02115
Alexander Hoffmann
*Department of Molecular Microbiology and Immunology, The Johns Hopkins University School of Public Health, Baltimore, Maryland 21205; ‡Department of Medicine, University of California, San Diego, La Jolla, California 92093; §Department of Biology, Massachusetts Institute of Technology, Boston, Massachusetts 02114; and ‖Department of Neurology and Program in Neuroscience, Harvard Medical School and Beth Israel-Deaconess Medical Center, Boston, Massachusetts 02115
J. Marie Hardwick
*Department of Molecular Microbiology and Immunology, The Johns Hopkins University School of Public Health, Baltimore, Maryland 21205; ‡Department of Medicine, University of California, San Diego, La Jolla, California 92093; §Department of Biology, Massachusetts Institute of Technology, Boston, Massachusetts 02114; and ‖Department of Neurology and Program in Neuroscience, Harvard Medical School and Beth Israel-Deaconess Medical Center, Boston, Massachusetts 02115
Rajiv R. Ratan
*Department of Molecular Microbiology and Immunology, The Johns Hopkins University School of Public Health, Baltimore, Maryland 21205; ‡Department of Medicine, University of California, San Diego, La Jolla, California 92093; §Department of Biology, Massachusetts Institute of Technology, Boston, Massachusetts 02114; and ‖Department of Neurology and Program in Neuroscience, Harvard Medical School and Beth Israel-Deaconess Medical Center, Boston, Massachusetts 02115
1. Abbreviations in this paper: EMSA, electrophoretic mobility shift assay; HA, hemagglutinin; M, mutant; NAC, N-acetylcysteine; R, reverse; SV, Sindbis virus; STS, staurosporine; wt, wild-type.
Address all correspondence to Rajiv R. Ratan, M.D., Ph.D., Neurology Laboratories at Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, Rm. 857; 77 Avenue Louis Pasteur, Boston, MA 02115.
Received:
January 26 1998
Revision Received:
April 22 1998
Online ISSN: 1540-8140
Print ISSN: 0021-9525
1998
J Cell Biol (1998) 141 (7): 1479–1487.
Article history
Received:
January 26 1998
Revision Received:
April 22 1998
Citation
Kuo-I Lin, Joseph A. DiDonato, Alexander Hoffmann, J. Marie Hardwick, Rajiv R. Ratan; Suppression of Steady-state, but not Stimulus-induced NF-κB Activity Inhibits Alphavirus-induced Apoptosis . J Cell Biol 29 June 1998; 141 (7): 1479–1487. doi: https://doi.org/10.1083/jcb.141.7.1479
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement